Cargando…
Transport Mechanisms and Their Pathology-Induced Regulation Govern Tyrosine Kinase Inhibitor Delivery in Rheumatoid Arthritis
BACKGROUND: Tyrosine kinase inhibitors (TKIs) are effective in treating malignant disorders and were lately suggested to have an impact on non-malignant diseases. However, in some inflammatory conditions like rheumatoid arthritis (RA) the in vivo effect seemed to be moderate. As most TKIs are taken...
Autores principales: | Schmidt-Lauber, Christian, Harrach, Saliha, Pap, Thomas, Fischer, Meike, Victor, Marion, Heitzmann, Marianne, Hansen, Uwe, Fobker, Manfred, Brand, Stefan-Martin, Sindic, Aleksandra, Pavenstädt, Hermann, Edemir, Bayram, Schlatter, Eberhard, Bertrand, Jessica, Ciarimboli, Giuliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527388/ https://www.ncbi.nlm.nih.gov/pubmed/23284953 http://dx.doi.org/10.1371/journal.pone.0052247 |
Ejemplares similares
-
Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts
por: Harrach, Saliha, et al.
Publicado: (2017) -
MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients
por: Harrach, S, et al.
Publicado: (2016) -
Role of transporters in the distribution of platinum-based drugs
por: Harrach, Saliha, et al.
Publicado: (2015) -
Interaction between bradykinin and urodilatin - a possible mechanism of clinical relevance
por: Dobrivojević, Marina, et al.
Publicado: (2011) -
Hydroxyfasudil-Mediated Inhibition of ROCK1 and ROCK2 Improves Kidney Function in Rat Renal Acute Ischemia-Reperfusion Injury
por: Kentrup, Dominik, et al.
Publicado: (2011)